In conclusion, our study establishes that TRIM28 expression in NSCLC plays a pivotal role in recruiting immunosuppressive MDSCs by activating the RIPK1-p65-CXCL1 axis, leading to the suppression of CD8+T cell activity and contributing to anti-PD-1 resistance. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.